(Press-News.org) Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to avoid kidney failure and stay alive. Despite the severity of the condition, there are currently no drugs available that improve kidney function. A research group led by Tohoku University Graduate School of Medicine’s Professor Takaaki Abe has found a remarkable solution to treat patients with CKD by co-opting a drug typically used for constipation. This is the first time that this drug (lubiprostone) was shown to prevent the decline of renal function in patients with CKD.
“We noticed that constipation is a symptom that often accompanies CKD, and decided to investigate this link further,” explains Abe. “Essentially, constipation disrupts the intestinal microbiota, which worsens kidney function. Working backwards, we hypothesized that we could improve kidney function by treating constipation.”
To address this issue, the group conducted a multicenter Phase II clinical trial (LUBI-CKD TRIAL) at nine Japanese medical institutions, enrolling 150 patients with moderate CKD. This study evaluated the effects of lubiprostone on kidney function. The results showed that, compared to the placebo group, the decline in kidney function (defined as the estimated glomerular filtration rate: eGFR) was suppressed in a dose-dependent manner in patients treated with 8 µg or 16 µg of lubiprostone.
The researchers also investigated the mechanism underlying how this effect occurred. They found that lubiprostone increases spermidine production, which improves mitochondrial function by promoting bacterial growth in the gut. The improved mitochondrial function was seen to exert a renoprotective effect – suppressing further kidney damage.
Going forward, the research team has plans to validate the trial results in a larger population (Phase 3 clinical trial) and advance the exploration of biomarkers that predict treatment efficacy. Their goal is to provide each patient with CKD the optimal treatment plan tailored to their needs. This discovery has the potential to significantly transform the conventional approach to CKD treatment, which primarily focuses on reducing uremic toxins.
These findings suggest a new therapeutic strategy in which laxatives suppress renal function decline. This strategy is expected to contribute to the development of treatments for not only CKD, but also mitochondrial dysfunction disorders. The results of this study were published in the scientific journal Science Advances on August 30, 2025.
END
World's first clinical trial showing lubiprostone aids kidney function
2025-08-29
ELSE PRESS RELEASES FROM THIS DATE:
Capturing language change through the genes
2025-08-29
Throughout human history, there have been many instances where two populations came into contact – especially in the past few thousand years because of large-scale migrations as a consequence of conquests, colonialization, and, more recently, globalization. During these encounters, not only did populations exchange genetic material, but also cultural elements.
When populations interact, they may borrow technologies, beliefs, practices, and also, crucially, aspects of language. With this, sounds, words or grammatical patterns can be exchanged ...
Public trust in elections increases with clear facts
2025-08-29
With control of Congress and a check on the Trump administration at issue in the 2026 midterm elections, the upcoming election cycle may again see claims of voter fraud.
But warning voters beforehand that there may be false claims about the election, and providing them with information on election security measures through "prebunking," can increase confidence in the results and decrease beliefs in voter fraud, according to a new study published in Science Advances.
"Prebunking is effective because it provides people with novel facts about how elections are ...
Thawing permafrost raised carbon dioxide levels after the last ice age
2025-08-29
Carbon dioxide levels in the atmosphere vary naturally between ice ages and interglacial periods. A new study by researchers at the University of Gothenburg shows that an unexpectedly large proportion of carbon dioxide emissions after the ice age may have come from thawing permafrost.
For a long time, it was the shifts between ice ages and interglacial periods that determined how much carbon dioxide was in the atmosphere. During ice ages, CO2 levels fell, only to rise by around 100 ppm (parts per million) during interglacial ...
New DNA test reveals plants’ hidden climate role
2025-08-29
Few of us ever think about what happens beneath our feet when we walk through a field of wheat or clover. We see the stalks, leaves, and flowers, but in practice we have no direct access to the roots.
Roots, however, are central. They anchor plants in the soil, supply them with water and nutrients, and contribute to carbon storage in the ground.
But because roots are hidden, researchers have for decades struggled to measure how much biomass lies below and how it is distributed among species.
“We have always known that roots are important, but we have lacked a precise tool to measure them. It’s a bit like studying marine ecosystems without ever being able to dive ...
Retinitis pigmentosa mouse models reflect pathobiology of human RP59
2025-08-29
BIRMINGHAM, Ala. – Retinitis pigmentosa retinal degeneration is caused by a family of hereditary mutations in nearly 100 genes that slowly lead to blindness over years or decades.
One of those genes encodes the enzyme DHDDS, part of the pathway that glycosylates proteins in higher cells. Retinitis pigmentosa from DHDDS mutations is called RP59. This is a recessive genetic disease, meaning mutations must be present on both copies of the DHDDS gene to cause disease.
To better understand and potentially treat RP59, Steven Pittler, Ph.D., and colleagues at the University of Alabama at Birmingham have created novel mouse models with mutations in the mouse gene for DHDDS.
Their first model, ...
Cell’s ‘antenna’ could be key to curing diseases
2025-08-29
Some might say it looks like a finger. Others might see a worm. Scientists in the field often liken it to an antenna. The technical name is primary cilium. This slender, microscopic appendage juts out from the surface of most cells in the human body — and yet for many years, it was completely missing from textbook illustrations.
Scientists began paying more attention to primary cilia around 2003. That’s when a scientist at Memorial Sloan Kettering Cancer Center (MSK), the late Kathryn Anderson, PhD, discovered that primary cilia play a hugely ...
Tiny ocean partnership between algae and bacteria reveals secrets of evolution
2025-08-29
The microscopic alliance between algae and bacteria offers rare, step-by-step snapshots of how bacteria lose genes and adapt to increasing host dependence. This is shown by a new study led by researchers from Stockholm University, in collaboration with the Swedish University of Agricultural Sciences and Linnaeus University, published in Current Biology.
In some of the most nutrient-poor waters of our oceans, tiny partnerships are hard at work keeping life going. These partnerships, called symbioses, are between microscopic algae known as diatoms and a specific bacteria called cyanobacteria that can take nitrogen ...
Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy
2025-08-29
An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialised immune cells. The discovery, published in Immunity, could pave the way for more precise and personalised cancer immunotherapies.
About the study: basic research // peer-reviewed // in vitro // in vivo // mice //
The team has taken an important step toward harnessing the immune system to fight cancer. Their work describes how they identified a genetic toolkit that programs two powerful subtypes of dendritic cells – key sentinels of the immune system. Dendritic cells are a diverse group of immune cells that act as the body’s ...
Blocking protein control pathway slows rhabdomyosarcoma growth in mice
2025-08-29
“Together, these findings confirm that proteostasis inhibition can slow RMS growth and suggest that targeting compensatory network components might yield synergistic outcomes.”
BUFFALO, NY – August 29, 2025 – A new research paper was published in Volume 16 of Oncotarget on August 29, 2025, titled “In vivo manipulation of the protein homeostasis network in rhabdomyosarcoma.”
In this study led by first author Kristen Kwong and corresponding author Amit J. Sabnis from the Department of Pediatrics, Division of Oncology, ...
2026 Hertz Fellowship Application Now Open
2025-08-29
The Hertz Foundation, a nonprofit dedicated to advancing American scientific and technological leadership, today announced that the application for the 2026 Hertz Fellowship is now open.
The Hertz Fellowship is one of the most competitive and coveted awards for doctoral students in applied sciences, engineering and mathematics. Hertz Fellows receive up to five years of funding, giving them freedom from the traditional constraints of graduate training and the independence needed to pursue groundbreaking research. They also gain lifelong professional support, including mentoring, events and networking opportunities.
Hertz Fellows join ...